We are "Kickin' the Tires, lightn' the fires, Stirrn' the melting pot of America and the World, You are listening to The Watchman On Warn Radio!"
I have followed the Bird flu for some time. It first came to my attention with some fervency when my friend Prophet Tom Deckard, a International Messianic Jewish Prophet and I spoke. He said “God had told him this was coming”.. I believe those were his words. When he says, God told him something, you can believe that is what he means. P.Tom gets open visions, and literally hears Gods voice. As well, he has seen many miraculous signs and wonders done by the Lord through his ministry in the years. Here is a story that I am posting for your information on this Bird Flu. Do not be fooled, according to Prophet Tom, there will be millions die from this. There is a way to escape, but the vaccine below won’t be a major deliverer from the B.Flu..
Prophet Toms site: http://www.jewishprophet.com/index.htm
G-d’s Glory Cloud
This Cloud has appeared to Bro. Deckard three times during the course of his ministry.
These pictures have been examined by experts proving there authenticity. When the cloud appears all manner of healings, miracles, salvation and deliverance comes to those who come in contact with the cloud. The cloud has demonstrated the glory of G-d to such extent that many of other religions fall on their faces and receive Jesus as their L-rd and Saviour.
The Watchman…
Here is the Story>>>
April 17, 2007, 2:05PM
FDA approves first bird flu vaccine for humans
By ANDREW BRIDGES
Associated Press
[chron.com/disp/story.mpl/nation/4722912.html]
Watchman Books Media Page
"There is Something I have been meaning to tell You!"
"Get 25% off The Watchman Books USE code BUYMYBOOK305 at checkout, good limited time from Lulu.com
WASHINGTON — A bird flu vaccine won federal approval for the first time today as a stopgap measure against a potential pandemic until more effective vaccines can be developed.
The vaccine is the first to win Food and Drug Administration approval for use in protecting humans against the H5N1 influenza virus. It would be used if the strain mutated into a form that spread easily from person to person, sparking a pandemic.
The Sanofi Aventis SA vaccine already is being stockpiled for use in an outbreak of bird flu. It will not be commercially available. Approval came on the recommendation of FDA advisers, who in February said the vaccine would be better than nothing.
“The threat of an influenza pandemic is, at present, one of the most significant public health issues our nation and world faces,” FDA commissioner Dr. Andrew von Eschenbach said. “The approval of this vaccine is an important step forward in our protection against a pandemic.”
The government plans to buy and stockpile enough bird flu vaccine for 20 million people, including emergency and health care workers. It also could be given to military personnel before they are deployed abroad.
In a clinical trial, the two-shot series appears to provide protection to just 45 percent of adults who received the highest dose. By comparison, seasonal flu shots, given singly, typically protect more than 90 percent of young, healthy adults.
Since it began ravaging Asian poultry farms in late 2003, the H5N1 strain of bird flu has infected nearly 300 people worldwide, killing more than half of them.
The Sanofi vaccine is given in two 90-microgram doses given about a month apart. The two shots contain 12 times the 15-microgram dose contained in regular winter flu shots.
“You’d like to respond to a pandemic quicker than that and ideally you’d like a vaccine where you had one dose and would need less antigen. Those types of vaccines are under study and development,” Norman Baylor, director of the FDA’s vaccine office, told reporters, adding later: “At this point, this is where we are.”
Those other studies are looking at the use of immune boosters, called adjuvants, to try to improve the effectiveness of the H5N1 vaccine. Eventually, adjuvants also might shrink the needed dose for a pandemic vaccine closer to what’s now used in seasonal shots.
Scientists also are studying the development of cell-based vaccines, which would be faster to produce in an outbreak of deadly flu than are current egg-based vaccines.
Sanofi called FDA approval “a first key step” in protecting people at increased risk of exposure to bird flu during the early stages of a pandemic. The shots are for adults ages 18 through 64.
Paris-based Sanofi makes the shots at a Swiftwater, Pa. plant run by its vaccines business, Sanofi Pasteur.
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Related posts:
